Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
3.350
-0.190 (-5.37%)
At close: Sep 24, 2026, 4:00 PM EDT
3.400
+0.050 (1.49%)
After-hours: Sep 24, 2026, 6:27 PM EDT
Protara Therapeutics Employees
Protara Therapeutics had 46 employees as of December 31, 2025. The number of employees increased by 18 or 64.29% compared to the previous year.
Employees
46
Change (1Y)
18
Growth (1Y)
64.29%
Revenue / Employee
n/a
Profits / Employee
-$1,522,065
Market Cap
197.97M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 46 | 18 | 64.29% | 46 | 0 |
| Dec 31, 2024 | 28 | 1 | 3.70% | 28 | 0 |
| Dec 31, 2023 | 27 | 2 | 8.00% | 26 | 1 |
| Dec 31, 2022 | 25 | -6 | -19.35% | 25 | 0 |
| Dec 31, 2021 | 31 | 4 | 14.81% | 31 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Protalix BioTherapeutics | 226 |
| Adagene | 128 |
| Nkarta | 106 |
| Alector | 103 |
| PepGen | 57 |
| ALX Oncology Holdings | 48 |
| Surrozen | 44 |
| Compass Therapeutics | 39 |
TARA News
- 9 days ago - Protara Therapeutics Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 16 days ago - Protara Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewsWire
- 6 weeks ago - Protara Therapeutics reports Q2 EPS (36c), consensus (31c) - TheFly
- 6 weeks ago - Protara Therapeutics Earnings release: Q2 2026 - Filings
- 6 weeks ago - Protara Therapeutics Quarterly report: Q2 2026 - Filings
- 4 months ago - Protara Therapeutics Transcript: 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA - Transcripts
- 4 months ago - Protara Therapeutics to Present at the TD Cowen 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA - GlobeNewsWire
- 4 months ago - Protara Therapeutics price target raised to $28 from $25 at Oppenheimer - TheFly